Free Trial

Sequoia Financial Advisors LLC Takes $330,000 Position in Exponent, Inc. $EXPO

Exponent logo with Business Services background

Key Points

  • Sequoia Financial Advisors LLC acquired a new stake in Exponent, Inc., purchasing 4,423 shares valued at approximately $330,000.
  • The company reported $0.52 earnings per share (EPS) for the last quarter, surpassing analysts' expectations of $0.48, with revenue increasing by 7.3% compared to the previous year.
  • Exponent also announced a quarterly dividend of $0.30 per share, with an annualized yield of 1.7% and a payout ratio of 60.00%.
  • MarketBeat previews the top five stocks to own by November 1st.

Sequoia Financial Advisors LLC acquired a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 4,423 shares of the business services provider's stock, valued at approximately $330,000.

A number of other hedge funds also recently modified their holdings of EXPO. Brooklyn Investment Group lifted its stake in shares of Exponent by 10,200.0% during the 1st quarter. Brooklyn Investment Group now owns 309 shares of the business services provider's stock worth $25,000 after buying an additional 306 shares during the last quarter. Bessemer Group Inc. raised its position in shares of Exponent by 103.3% in the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after buying an additional 346 shares in the last quarter. SVB Wealth LLC acquired a new position in shares of Exponent in the 1st quarter valued at approximately $80,000. Caitong International Asset Management Co. Ltd grew its holdings in shares of Exponent by 8,092.9% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider's stock valued at $93,000 after purchasing an additional 1,133 shares during the last quarter. Finally, Covestor Ltd grew its holdings in shares of Exponent by 43.7% during the 1st quarter. Covestor Ltd now owns 1,785 shares of the business services provider's stock valued at $145,000 after purchasing an additional 543 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.

Exponent Stock Up 1.2%

Exponent stock opened at $69.92 on Wednesday. Exponent, Inc. has a 12-month low of $63.81 and a 12-month high of $112.75. The firm's fifty day moving average is $69.54 and its 200 day moving average is $73.64. The company has a market capitalization of $3.53 billion, a PE ratio of 34.96 and a beta of 0.91.

Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The company had revenue of $132.87 million for the quarter, compared to the consensus estimate of $130.82 million. During the same quarter in the previous year, the company earned $0.57 EPS. Exponent's quarterly revenue was up 7.3% compared to the same quarter last year. Sell-side analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Friday, September 5th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, September 5th. This represents a $1.20 annualized dividend and a yield of 1.7%. Exponent's dividend payout ratio is presently 60.00%.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Exponent in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of "Hold".

Get Our Latest Stock Report on EXPO

Insider Buying and Selling at Exponent

In related news, CEO Catherine Corrigan sold 4,930 shares of the stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $66.82, for a total transaction of $329,422.60. Following the completion of the transaction, the chief executive officer owned 82,753 shares in the company, valued at approximately $5,529,555.46. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Joseph Sala sold 1,595 shares of the stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total transaction of $112,670.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,326 shares of company stock worth $1,133,059. Corporate insiders own 1.60% of the company's stock.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.